Local treatment of inflammation (short-term)
Short term local treatment of inflammation (severe conditions)
Single use eye drops to be used only when a preservative free preparation is necessary
Dexamethasone (Maxidex) is classified as a corticosteroid (glucocorticosteroid). Steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe (eg, allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitides when the inherent hazard of steroid use is accepted to obtain an advisable diminution in edema and inflammation)
| Pack | Price |
|---|---|
| 10 ml | |
| 5 ml | £1.42 |
| Pack | Price |
|---|---|
| 20 unit dose | £11.53 |
Inflammatory eye conditions
Single use eye drops to be used only when a preservative free preparation is necessary
| Pack | Price |
|---|---|
| 10 ml | £29.47 |
| Pack | Price |
|---|---|
| 20 unit dose | £14.39 |
Diabetic Macular oedema
Brand: Ozurdex
Rationale 1,2
NICE TA 349 Dexamethasone intravitreal implant for treating diabetic macular oedema
Dexamethasone intravitreal implant (Ozurdex) is recommended as a possible treatment for people with sight problems caused by diabetic macular oedema if:
*there is an artificial lens in the eye to be treated, and
*their diabetic macular oedema has not improved with non-corticosteroid treatment, or such treatment is not suitable for them.
NICE TA229 Dexamethasone intravitreal implant for the treatment of macular oedema secondary to retinal vein occlusion. Dexamethasone 700microgram intravitreal implant is prescribable in line with NICE guidance
Treatment of mild non-infectious allergic or inflammatory conjunctival diseases
| Pack | Price |
|---|---|
| 10 ml |